|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating expenses: | ||||
| Professional fees | ||||
| General and administrative | ||||
| Franchise tax expense | ||||
| Research and development | ||||
| Share-based compensation | ||||
| Net operating loss | ||||
| Interest earned on investment held in Trust Account | ||||
| Other income (expense): | ||||
| Interest expense | ||||
| Change in fair value of warrant liability | ||||
| Settlement expense | ||||
| Other income (expense) | ||||
| Total other income (expense) | ||||
| Net loss before income taxes | ||||
| Income taxes | ||||
| Net loss | ||||
| Net loss per share: Basic (in Dollars per share) | ||||
| Redeemable Common Stock | ||||
| Non-Redeemable Common Stock | ||||
| Total net loss per share: Basic (in Dollars per share) | ||||
| Net loss per share: Diluted (in Dollars per share) | ||||
| Redeemable Common Stock | ||||
| Non-Redeemable Common Stock | ||||
| Total net loss per share: Diluted (in Dollars per share) | ||||
| Weighted average common shares outstanding (in Shares) | ||||
| Redeemable Common Stock | ||||
| Non-Redeemable Common Stock | ||||
| Total weighted average common shares outstanding (in Shares) | ||||
Loading...